Select Eye Care
Elkridge, Maryland, 21075, United States
Location status: Recruiting
NCT Number: NCT07147647
The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian participants with primary open angle glaucoma. The main question it aims to answer is:
What is the washed out eye pressure (eye pressure when not on any glaucoma medications) of participants 6 months after the Direct Selective Laser Trabeculoplasty (DSLT) procedure compared to the washed out eye pressure of participants prior to the DSLT procedure.
Participants will:
Undergo the DSLT procedure in one or both eyes and visit the clinic 1 month, 3 months, and 6 months after the procedure to have their vision and eye pressure measured.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Elkridge, Maryland, 21075, United States
Location status: Recruiting
The goal of this clinical trial is to evaluate intraocular pressure (IOP) reduction of Direct Selective Laser Trabeculoplasty (DSLT) treatment in eyes of non-Caucasian patients with primary open angle glaucoma by assessing the washed out IOP reduction of DSLT at 6 months (compared to washed out baseline IOP), measuring the success rate of achieving ≥ to 20% IOP reduction from washed out baseline, assessing the proportion of medication-free eyes at 6 months post-DSLT, the need for secondary intervention (additional medications or procedures) at 6 months post-DSLT, and by comparing the washed out IOP reduction at 6 months post-DSLT compared to the washed out baseline IOP according to trabecular meshwork pigmentation grade.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
DSLT using the Belkin Vision Eagle Device
Time frame: 6 Months post-DSLT
Time frame: 6 months post-DSLT
Time frame: 6 Months Post-DSLT
Eyes not using any glaucoma medications
Time frame: 6 Months Post-DSLT
Time frame: 6 Months Post-DSLT
Time frame: 1 month and 3 months post-DSLT
Measured in mmHg by Goldmann Applanation Tonometry
Time frame: 6 Month Post-DSLT
Trabecular meshwork pigment will be graded on a scale of 0-4 where 0 is no pigment and 4 is heavy pigmentation
Contact information is provided by the study sponsor or research team.
Select Eye Care
Industry
Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Intraocular Pressure in Non-Caucasian Open Angle Glaucoma Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07322965
Eye Diseases, Glaucoma
Barcelona, Spain
View Trial DetailsNCT06792422
Eye Diseases, Glaucoma
Glostrup Municipality, Denmark
View Trial DetailsNCT06615661
Eye Diseases, Glaucoma
Cape Coral, Florida, United States
View Trial DetailsNCT06016972
Eye Diseases, Glaucoma
Roswell, Georgia, United States
View Trial Details